Keywords
Abstract
Metabolic syndrome, characterized by a constellation of metabolic abnormalities, including central obesity, insulin resistance, hypertension, and dyslipidemia, poses a significant risk for the development of atherosclerotic cardiovascular diseases and type II diabetes mellitus. The diagnosis of metabolic syndrome necessitates the presence of 3 or more of these metabolic abnormalities, signaling an urgent need for proactive identification and intervention strategies. The prevalence of MetS is rapidly increasing worldwide, largely as a consequence of the ongoing obesity epidemic. Environmental factors during periods early in development have been shown to influence the susceptibility to develop disease in later life. In particular, there is a wealth of evidence from both epidemiological and animal studies for greater incidence of features of MetS as a result of unbalanced maternal nutrition. The mechanisms by which nutritional insults during a period of developmental plasticity result in a MetS phenotype are now beginning to receive considerable scientific interest.
References
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease
Grundy SM. Metabolic syndrome: therapeutic considerations
Ferrannini E. Metabolic syndrome: a solution in search of a problem
Campion J, Milagro FI, Martinez JA. Individuality and epigenetics in obesity
Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis Diabetologia., 35 (1992), pp. 595-601
Godfrey KM. Maternal regulation of fetal development and health in adult life
Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23. [PubMed]
Kazemi T, Sharifzadeh G, Zarban A, Fesharakinia A. Comparison of components of metabolic syndrome in premature myocardial infarction in an Iranian population: a case -control study. Int J Prev Med. 2013 Jan;4(1):110- [PMC free article] [PubMed]
Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacol Res. 2017 Jun;120:34-42. [PubMed]
Caballero B. Humans against Obesity: Who Will Win? Adv Nutr. 2019 Jan 01;10(suppl_1): S4-S9. [PMC free article] [PubMed]
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017 Jan 03;127(1):1-4. [PMC free article] [PubMed]
Matsuzawa Y, Funahashi T, Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb. 2011;18(8):629-39. [PubMed]
Handelsman Y. Metabolic syndrome pathophysiology and clinical presentation. Toxicol Pathol. 2009 Jan;37(1):18-20. [PubMed]
van der Pal KC, Koopman ADM, Lakerveld J, van der Heijden AA, Elders PJ, Beulens JW, Rutters F. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: the New Hoorn study. Sleep Med. 2018 Dec; 52:51-57. [PubMed]
Kim JY, Yi ES. Analysis of the relationship between physical activity and metabolic syndrome risk factors in adults with intellectual disabilities. J Exerc Rehabil. 2018 Aug;14(4):592-597. [PMC free article] [PubMed]
Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of Metabolic Syndrome and Dietary Intervention. Int J Mol Sci. 2018 Dec 31;20(1) [PMC free article] [PubMed]
Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak D, Isenovic ER. Link between Metabolic Syndrome and Insulin Resistance. Curr Vasc Pharmacol. 2017;15(1):30-39. [PubMed]
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022 Jan 12;23(2) [PMC free article] [PubMed]